Symbols / ADGM $1.07 +0.00%
ADGM Chart
About
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 22.66M |
| Enterprise Value | 39.96M | Income | -79.15M | Sales | 137.00K |
| Book/sh | -0.09 | Cash/sh | 0.22 | Dividend Yield | — |
| Payout | 0.00% | Employees | 80 | IPO | — |
| P/E | — | Forward P/E | -1.08 | PEG | — |
| P/S | 165.42 | P/B | -12.59 | P/C | — |
| EV/EBITDA | -1.56 | EV/Sales | 291.65 | Quick Ratio | 0.48 |
| Current Ratio | 0.84 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -2.44 | EPS next Y | -0.99 | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -24.12% |
| ROE | -210.36% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -195.44% | Profit Margin | 0.00% | Shs Outstand | 21.18M |
| Shs Float | 3.78M | Short Float | 0.67% | Short Ratio | 1.54 |
| Short Interest | — | 52W High | 2.87 | 52W Low | 0.62 |
| Beta | 0.14 | Avg Volume | 101.43K | Volume | 119.68K |
| Target Price | $4.00 | Recom | None | Prev Close | $1.07 |
| Price | $1.07 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-02 | init | Lake Street | — → Buy | $4 |
- Adagio Medical Holdings Inc. Stock (ADGM) Opinions on Insider Purchase - Quiver Quantitative ue, 16 Dec 2025 08
- Ondo Finance tokenized stocks platform on Binance wins regulatory approval in Abu Dhabi - CoinDesk ue, 03 Mar 2026 08
- Pleasing Signs As A Number Of Insiders Buy Adagio Medical Holdings Stock - simplywall.st Sat, 24 Jan 2026 08
- Usen Todd, CEO of Adagio Medical, buys $225k in Adagio stock - Investing.com Mon, 15 Dec 2025 08
- Tokenized Stocks Achieve Landmark Victory as Ondo Finance Secures Abu Dhabi Trading Approval - CryptoRank Sun, 15 Mar 2026 12
- UBS opens new Advisory Office in ADGM - UBS Wed, 15 Oct 2025 07
- Binance Gains ADGM Approval for Ondo Tokenized Stocks - CoinCentral ue, 03 Mar 2026 14
- Circle secures ADGM license (CRCL:NYSE) - Seeking Alpha ue, 09 Dec 2025 08
- UAE climate law tightens carbon reporting; Diginex deepens Abu Dhabi role - Stock Titan ue, 24 Feb 2026 08
- Insider Purchase: Chief Executive Officer of $ADGM Buys 207,315 Shares - Quiver Quantitative ue, 16 Dec 2025 08
- Binance launches trading of Ondo tokenized stocks on regulated ADGM platform - Traders Union Wed, 04 Mar 2026 11
- Fintech Startup Tabadulat Receives In-Principle Approval From ADGM’s FSRA - Fintech Finance ue, 29 Jul 2025 07
- Ondo secures approval to trade tokenized stocks, ETFs in Abu Dhabi - Bitget Mon, 02 Mar 2026 23
- Circle (CRCL) Stock Wavers as USDC Issuer Secures ADGM License in the UAE - CoinGape ue, 09 Dec 2025 08
- Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Benzinga ue, 16 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 15000 | 17973 | — | Purchase at price 1.20 per share. | KASTER DEBORAH | Chief Financial Officer | — | 2025-12-16 00:00:00 | D |
| 1 | 207315 | 225973 | — | Purchase at price 1.09 per share. | USEN TODD | Chief Executive Officer | — | 2025-12-12 00:00:00 | D |
| 2 | 64167 | — | — | Stock Award(Grant) at price 0.00 per share. | PERCEPTIVE ADVISORS, L.L.C. | Unknown | — | 2025-01-22 00:00:00 | D |
Financials
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -35.91M | -23.04M | -20.35M |
| TotalUnusualItems | -42.00K | 0.00 | 744.00K |
| TotalUnusualItemsExcludingGoodwill | -42.00K | 0.00 | 744.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -38.15M | -23.67M | -19.94M |
| ReconciledDepreciation | 532.00K | 495.00K | 336.00K |
| ReconciledCostOfRevenue | 1.31M | 875.00K | 1.16M |
| EBITDA | -35.95M | -23.04M | -19.60M |
| EBIT | -36.49M | -23.54M | -19.94M |
| NetInterestIncome | -1.66M | -98.00K | 3.00K |
| InterestExpense | 1.66M | 137.00K | 0.00 |
| InterestIncome | 3.00K | 39.00K | 3.00K |
| NormalizedIncome | -38.10M | -23.67M | -20.68M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -38.15M | -23.67M | -19.94M |
| TotalExpenses | 28.24M | 24.10M | 20.91M |
| TotalOperatingIncomeAsReported | -27.94M | -23.91M | -20.64M |
| DilutedAverageShares | 13.39M | 13.39M | 13.39M |
| BasicAverageShares | 13.39M | 13.39M | 13.39M |
| DilutedEPS | -2.85 | -1.77 | -1.49 |
| BasicEPS | -2.85 | -1.77 | -1.49 |
| DilutedNIAvailtoComStockholders | -38.15M | -23.67M | -19.94M |
| NetIncomeCommonStockholders | -38.15M | -23.67M | -19.94M |
| NetIncome | -38.15M | -23.67M | -19.94M |
| NetIncomeIncludingNoncontrollingInterests | -38.15M | -23.67M | -19.94M |
| NetIncomeContinuousOperations | -38.15M | -23.67M | -19.94M |
| PretaxIncome | -38.15M | -23.67M | -19.94M |
| OtherIncomeExpense | -8.55M | 338.00K | 704.00K |
| OtherNonOperatingIncomeExpenses | -8.51M | 338.00K | -40.00K |
| SpecialIncomeCharges | -8.49M | 0.00 | 744.00K |
| OtherSpecialCharges | 8.49M | -744.00K | |
| GainOnSaleOfSecurity | -42.00K | ||
| NetNonOperatingInterestIncomeExpense | -1.66M | -98.00K | 3.00K |
| InterestExpenseNonOperating | 1.66M | 137.00K | 0.00 |
| InterestIncomeNonOperating | 3.00K | 39.00K | 3.00K |
| OperatingIncome | -27.94M | -23.91M | -20.64M |
| OperatingExpense | 26.94M | 23.23M | 19.76M |
| ResearchAndDevelopment | 15.40M | 17.86M | 15.36M |
| SellingGeneralAndAdministration | 11.54M | 5.37M | 4.40M |
| GrossProfit | -1.01M | -686.00K | -888.00K |
| CostOfRevenue | 1.31M | 875.00K | 1.16M |
| TotalRevenue | 300.00K | 189.00K | 270.00K |
| OperatingRevenue | 300.00K | 189.00K | 270.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 15.20M | 14.54M | 13.39M | 13.39M |
| ShareIssued | 15.20M | 14.54M | 13.39M | 13.39M |
| NetDebt | 36.88M | 3.95M | ||
| TotalDebt | 16.27M | 38.40M | 9.80M | 0.00 |
| TangibleBookValue | -1.02M | -132.02M | -95.88M | -72.62M |
| InvestedCapital | 35.99M | -93.75M | -86.38M | -72.62M |
| WorkingCapital | 17.59M | -41.99M | -6.24M | 17.14M |
| NetTangibleAssets | -1.02M | -132.02M | -95.88M | -72.62M |
| CapitalLeaseObligations | 189.00K | 131.00K | 297.00K | 0.00 |
| CommonStockEquity | 19.91M | -132.02M | -95.88M | -72.62M |
| TotalCapitalization | 35.99M | -131.88M | -95.88M | -72.62M |
| TotalEquityGrossMinorityInterest | 19.91M | -132.02M | -95.88M | -72.62M |
| StockholdersEquity | 19.91M | -132.02M | -95.88M | -72.62M |
| GainsLossesNotAffectingRetainedEarnings | 1.00K | 17.00K | 28.00K | 4.00K |
| OtherEquityAdjustments | 1.00K | 17.00K | 28.00K | 4.00K |
| RetainedEarnings | -70.59M | -133.65M | -97.06M | -73.39M |
| AdditionalPaidInCapital | 90.50M | 1.61M | 1.15M | 763.00K |
| CapitalStock | 2.00K | 1.00K | 1.00K | 1.00K |
| CommonStock | 2.00K | 1.00K | 1.00K | 1.00K |
| TotalLiabilitiesNetMinorityInterest | 28.54M | 138.85M | 104.57M | 94.06M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 20.77M | 91.67M | 91.61M | 91.47M |
| OtherNonCurrentLiabilities | 3.62M | 8.00K | 3.00K | 5.00K |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 91.47M | 91.47M | 91.47M |
| DerivativeProductLiabilities | 152.00K | 0.00 | ||
| NonCurrentDeferredLiabilities | 883.00K | 0.00 | ||
| NonCurrentDeferredTaxesLiabilities | 883.00K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 16.12M | 195.00K | 134.00K | 0.00 |
| LongTermCapitalLeaseObligation | 46.00K | 52.00K | 134.00K | 0.00 |
| LongTermDebt | 16.08M | 143.00K | ||
| CurrentLiabilities | 7.76M | 47.18M | 12.97M | 2.59M |
| OtherCurrentLiabilities | 78.00K | |||
| CurrentDebtAndCapitalLeaseObligation | 143.00K | 38.20M | 9.66M | |
| CurrentCapitalLeaseObligation | 143.00K | 79.00K | 163.00K | 0.00 |
| CurrentDebt | 38.12M | 9.50M | ||
| OtherCurrentBorrowings | 38.12M | 9.50M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.62M | 1.57M | 1.23M | 843.00K |
| PayablesAndAccruedExpenses | 5.00M | 7.33M | 2.08M | 1.75M |
| CurrentAccruedExpenses | 2.16M | 3.50M | 1.06M | 1.17M |
| Payables | 2.84M | 3.83M | 1.01M | 578.00K |
| AccountsPayable | 2.84M | 3.83M | 1.01M | 578.00K |
| TotalAssets | 48.45M | 6.83M | 8.70M | 21.44M |
| TotalNonCurrentAssets | 23.10M | 1.64M | 1.97M | 1.72M |
| OtherNonCurrentAssets | 14.00K | 23.00K | 26.00K | 22.00K |
| GoodwillAndOtherIntangibleAssets | 20.94M | 0.00 | ||
| OtherIntangibleAssets | 6.97M | |||
| Goodwill | 13.97M | 0.00 | ||
| NetPPE | 2.15M | 1.62M | 1.94M | 1.70M |
| AccumulatedDepreciation | -2.73M | -1.78M | -1.24M | -772.00K |
| GrossPPE | 4.88M | 3.39M | 3.18M | 2.47M |
| Leases | 306.00K | 305.00K | 303.00K | 303.00K |
| ConstructionInProgress | 0.00 | 54.00K | 54.00K | 28.00K |
| OtherProperties | 3.57M | 1.98M | 1.84M | 255.00K |
| MachineryFurnitureEquipment | 1.00M | 1.05M | 977.00K | 1.88M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 25.35M | 5.18M | 6.73M | 19.72M |
| OtherCurrentAssets | 222.00K | 177.00K | 527.00K | 241.00K |
| PrepaidAssets | 1.94M | 232.00K | 291.00K | 263.00K |
| Inventory | 2.57M | 3.32M | 367.00K | 334.00K |
| FinishedGoods | 495.00K | 914.00K | 367.00K | 334.00K |
| WorkInProcess | 388.00K | 197.00K | 0.00 | |
| RawMaterials | 1.68M | 2.21M | 0.00 | |
| Receivables | 35.00K | 71.00K | 0.00 | 33.00K |
| AccountsReceivable | 35.00K | 71.00K | 0.00 | 33.00K |
| CashCashEquivalentsAndShortTermInvestments | 20.59M | 1.38M | 5.55M | 18.85M |
| CashAndCashEquivalents | 20.59M | 1.38M | 5.55M | 18.85M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| FreeCashFlow | -25.99M | -22.91M | -20.58M |
| RepaymentOfDebt | -1.14M | 0.00 | |
| IssuanceOfDebt | 23.00M | 9.50M | 0.00 |
| CapitalExpenditure | -340.00K | -502.00K | -1.27M |
| InterestPaidSupplementalData | 208.00K | 0.00 | |
| EndCashPosition | 1.38M | 5.55M | 18.85M |
| BeginningCashPosition | 5.55M | 18.85M | 39.23M |
| EffectOfExchangeRateChanges | -47.00K | 81.00K | 69.00K |
| ChangesInCash | -4.12M | -13.39M | -20.45M |
| FinancingCashFlow | 21.88M | 9.53M | 130.00K |
| CashFlowFromContinuingFinancingActivities | 21.88M | 9.53M | 130.00K |
| ProceedsFromStockOptionExercised | 18.00K | 25.00K | 130.00K |
| NetIssuancePaymentsOfDebt | 21.86M | 9.50M | 0.00 |
| NetShortTermDebtIssuance | 20.00M | 9.50M | 0.00 |
| ShortTermDebtIssuance | 20.00M | 9.50M | 0.00 |
| NetLongTermDebtIssuance | 21.86M | 9.50M | 0.00 |
| LongTermDebtPayments | -1.14M | 0.00 | |
| LongTermDebtIssuance | 23.00M | 9.50M | 0.00 |
| InvestingCashFlow | -340.00K | -500.00K | -1.27M |
| CashFlowFromContinuingInvestingActivities | -340.00K | -500.00K | -1.27M |
| NetIntangiblesPurchaseAndSale | -7.00K | -10.00K | -14.00K |
| PurchaseOfIntangibles | -7.00K | -10.00K | -14.00K |
| NetPPEPurchaseAndSale | -333.00K | -490.00K | -1.26M |
| SaleOfPPE | 0.00 | 2.00K | 0.00 |
| PurchaseOfPPE | -333.00K | -492.00K | -1.26M |
| OperatingCashFlow | -25.65M | -22.41M | -19.31M |
| CashFlowFromContinuingOperatingActivities | -25.65M | -22.41M | -19.31M |
| ChangeInWorkingCapital | 2.79M | 330.00K | 579.00K |
| ChangeInOtherCurrentLiabilities | -161.00K | -148.00K | -15.00K |
| ChangeInPayablesAndAccruedExpense | 5.59M | 730.00K | 1.07M |
| ChangeInAccruedExpense | 2.77M | 294.00K | 792.00K |
| ChangeInPayable | 2.82M | 436.00K | 279.00K |
| ChangeInAccountPayable | 2.82M | 436.00K | 279.00K |
| ChangeInPrepaidAssets | 410.00K | -320.00K | -44.00K |
| ChangeInInventory | -2.98M | 35.00K | -473.00K |
| ChangeInReceivables | -70.00K | 33.00K | 40.00K |
| ChangesInAccountReceivables | -70.00K | 33.00K | 40.00K |
| OtherNonCashItems | 8.66M | 147.00K | |
| StockBasedCompensation | 442.00K | 365.00K | 339.00K |
| AssetImpairmentCharge | 25.00K | -76.00K | 121.00K |
| DepreciationAmortizationDepletion | 532.00K | 495.00K | 336.00K |
| DepreciationAndAmortization | 532.00K | 495.00K | 336.00K |
| OperatingGainsLosses | 45.00K | -744.00K | |
| GainLossOnInvestmentSecurities | 42.00K | ||
| GainLossOnSaleOfPPE | 3.00K | 0.00 | |
| NetIncomeFromContinuingOperations | -38.15M | -23.67M | -19.94M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ADGM
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|